title: Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.
abstract: Behçet's disease is a chronic inflammatory disease characterized by recurrent oral aphthae and systemic manifestations. Gastrointestinal involvement is rare. We report a case of ileocolitis secondary to Behçet's successfully treated with tumor necrosis factor-alpha antibody (infliximab) therapy. To our knowledge this is the second reported case of Behçet's ileocolitis successfully treated with anti-tumor necrosis factor therapy.
authors.affiliation: Department of Gastroenterology, Nyack Hospital, New York, USA.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Kram
authors.forename: Louis D
authors.initials: LD
authors.lastname: May
authors.forename: Stephen
authors.initials: S
authors.lastname: Goodman
authors.forename: Sharon
authors.initials: S
authors.lastname: Molinas
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000473:pathology; D003092:Colitis / Q000188:drug therapy* / Q000473:pathology; D003113:Colonoscopy; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007079:Ileitis / Q000188:drug therapy* / Q000473:pathology; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab